Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson’s Disease
Table 2
Descriptive statistics of median split groups.
Clock Drawing Test
ROCF
Block Design Test
Digit Span
Incorrectly drawn
Correctly drawn
A
B
A
B
A
B
Allocation
Median
Median
p
Median
Median
p
Median
Median
p
Median
Median
p
Sex (M/F)
11/5
29/12
1.000
19/9
20/7
.833
20/9
19/8
1.000
20/9
20/8
1.000
Age
67.5
67
.930
66.5
69.0
.295
67.0
69.0
.384
67.0
67.5
.994
Education
15
15
.964
14
15
.572
14
15
.092.
15
15
.413
UPDRS III
13.5
13.5
.765
17.0
10.0
.166
15.5
13.0
.511
14.0
13.5
.818
MMSE
28.5
29
29
29
.347
29
29
.209
29
29
.322
Disease duration
5.27
3.37
.160
4.30
3.24
.508
4.12
3.37
.558
2.94
4.74
Dose of L-dopa
666
510
.247
650
495
.206
590
550
.906
510
585
.296
BDI
4.5
8.0
6.5
7.18
.901
6.5
7.35
.655
7
7
.941
Note. Values are expressed by median; UPDRS III = Unified Parkinson’s Disease Rating Scale subscale III (range 0–108); MMES = Mini-Mental State Examination (range 0–30); BDI = Beck Depression Inventory (range 0–63); ROCF = Rey-Osterrieth Complex Figure Test; A = group with lower tasks performance; B = group with higher tasks performance; , .
